Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H26O3 |
| Molecular Weight | 302.4079 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])C(=O)C=C4C[C@@H](O)CC[C@]34C
InChI
InChIKey=KPRGOTLNGIBVFL-GINZOMEDSA-N
InChI=1S/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-14,17,20H,3-9H2,1-2H3/t12-,13-,14-,17-,18-,19-/m0/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Biosynthesis of [3H]7 alpha-hydroxy-, 7 beta-hydroxy-, and 7-oxo-dehydroepiandrosterone using pig liver microsomal fractions. | 2004 Oct 1 |
|
| Delayed effects of short-term transdermal application of 7-oxo-dehydroepiandrosterone on its metabolites, some hormonal steroids and relevant proteohormones in healthy male volunteers. | 2005 |
|
| Steroids and thermogenesis. | 2006 |
|
| How short-term transdermal treatment of men with 7-oxo-dehydroepiandrosterone influence thyroid function. | 2006 |
|
| A novel radioimmunoassay of 7-oxo-DHEA and its physiological levels. | 2007 Apr |
|
| Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. | 2007 May |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
395 (Number of products:72)
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C002914
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
2334LJD2E9
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
7-KETO-DHEA
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
566-19-8
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
2334LJD2E9
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
193313
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
SUB120413
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
100000143492
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | |||
|
1427084
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID801024029
Created by
admin on Fri Dec 15 16:58:53 GMT 2023 , Edited by admin on Fri Dec 15 16:58:53 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
